58 related articles for article (PubMed ID: 9823645)
41. Corrigendum to "Manual calf massage and passive ankle motion reduce the incidence of deep vein thromboembolism after total hip arthroplasty" [J Orthop Sci 22 (2017) 726-730].
Imai N; Ito T; Suda K; Miyasaka D; Endo N
J Orthop Sci; 2018 May; 23(3):608. PubMed ID: 29454546
[No Abstract] [Full Text] [Related]
42. Tubercular infection presenting as sinus over ankle joint after knee replacement surgery.
Uppal S; Garg R
J Glob Infect Dis; 2010 Jan; 2(1):71-2. PubMed ID: 20300424
[No Abstract] [Full Text] [Related]
43. Opioids in Total Joint Arthroplasty: Moving Forward.
Halawi MJ; Lieberman JR
J Arthroplasty; 2018 Aug; 33(8):2341-2343. PubMed ID: 29903460
[No Abstract] [Full Text] [Related]
44. Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty.
He ML; Xiao ZM; Lei M; Li TS; Wu H; Liao J
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD008207. PubMed ID: 25069620
[TBL] [Abstract][Full Text] [Related]
45. [CPM--Continuous Passive Motion: treatment of injured or operated knee-joints using passive movement. A meta-analysis of current literature].
Kirschner P
Unfallchirurg; 2004 Apr; 107(4):328-40. PubMed ID: 15060772
[TBL] [Abstract][Full Text] [Related]
46. [Comparison between low-molecular and unfractionated heparin in the prevention of thrombosis in patients with total endoprosthetic replacement of hip and knee joint].
Rader CP; Kramer C; König A; Gohlke F; Eulert J
Z Orthop Ihre Grenzgeb; 1997; 135(1):52-7. PubMed ID: 9199074
[TBL] [Abstract][Full Text] [Related]
47. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
Delis KT; Hunt N; Strachan RK; Nicolaides AN
Thromb Haemost; 2001 Sep; 86(3):817-21. PubMed ID: 11583313
[TBL] [Abstract][Full Text] [Related]
48. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
[TBL] [Abstract][Full Text] [Related]
49. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
50. [Restricted motion after total knee arthroplasty].
Kucera T; Urban K; Karpas K; Sponer P
Acta Chir Orthop Traumatol Cech; 2007 Oct; 74(5):326-31. PubMed ID: 18001629
[TBL] [Abstract][Full Text] [Related]
51. [Experiences with an ankle joint motion device in prevention of thrombosis in patients after total endoprosthesis knee replacement].
Rader CP; Kramer C; Hendrich C; König A; Gohlke F; Eulert J
Z Orthop Ihre Grenzgeb; 1998; 136(5):467-70. PubMed ID: 9823645
[TBL] [Abstract][Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
